5 November 2024
Microsaic Systems plc
("Microsaic" or the "Company")
Update on Publication of Interim Results
Further to the announcement of its FY23 financial results on 11 October 2024, Microsaic Systems plc (AIM: MSYS), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, announces its interim financial results for the period ended 30 June 2024 ("H124") are now expected to be released in the first half of November.
| Microsaic Systems plc Bob Moore, Acting Executive Chairman | +44 (0) 20 3657 0050 via TPI |
|
|
|
| Singer Capital Markets (Nominated Adviser) Alex Bond / Oliver Platts | +44 (0)20 7496 3000 |
|
|
|
| Turner Pope Investments (TPI) Limited (Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 |
About Microsaic Systems Group
Microsaic is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has recently acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities.
Microsaic's products and solutions are commercially available through global markets via a network of regional and country specific distributors and partners.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.